|
|
|
| home > white papers > Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands - West Pharmaceutical Services, Inc. |
|
|
 WHITE PAPERS |
|
West Pharmaceutical Services, Inc.
|
|
Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands
|
|
The current pharmaceutical market has faced a variety of challenges,
including increasing expectations for quality from end-users and
regulatory agencies driven by concern for patient safety. While
pharmaceutical companies are working to assure that new quality and
compliance paradigms are met, a balance must be achieved between the
reality of managing costs in an effort to provide a product that meets
the requirements of payers along with facilitating profitability in
order to continue adequate business reinvestment.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Saneca to drive R&D Initiative following €1.5 million funding
More info >> |
|
 |
White Papers |
 |
|
The Impact of Components on Drug Quality and Risk Mitigation
West Pharmaceutical Services, Inc.
Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >> |
|
 |
Industry Events |
 |
7th annual Orphan Drugs and Rare Diseases UK
18-19 October 2017, Holiday Inn Kensington Forum, London
SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >> |
|
|
|
